Drug
Information |
Name | (+/-)-nantenine |
Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format |
Target | Serotonin 5a (5-HT5a) receptor |  | Inhibitor | [1] |
Serotonin 6 (5-HT6) receptor |  | Inhibitor | [1] |
Alpha-1b adrenergic receptor |  | Inhibitor | [1] |
Alpha-2a adrenergic receptor |  | Inhibitor | [1] |
Alpha-2c adrenergic receptor |  | Inhibitor | [1] |
Dopamine D1 receptor |  | Inhibitor | [1] |
Dopamine D3 receptor |  | Inhibitor | [1] |
Serotonin 2c (5-HT2c) receptor |  | Inhibitor | [1] |
Serotonin 2b (5-HT2b) receptor |  | Inhibitor | [1] |
Serotonin 2a (5-HT2a) receptor |  | Inhibitor | [1] |
Serotonin 1d (5-HT1d) receptor |  | Inhibitor | [1] |
Serotonin 1b (5-HT1b) receptor |  | Inhibitor | [1] |
Mu opioid receptor |  | Inhibitor | [1] |
Histamine H2 receptor |  | Inhibitor | [1] |
Dopamine D5 receptor |  | Inhibitor | [1] |
Dopamine D4 receptor |  | Inhibitor | [1] |
Dopamine D2 receptor |  | Inhibitor | [1] |
Beta-1 adrenergic receptor |  | Inhibitor | [1] |
Alpha-2b adrenergic receptor |  | Inhibitor | [1] |
Alpha-1d adrenergic receptor |  | Inhibitor | [1] |
Alpha-1a adrenergic receptor |  | Inhibitor | [1] |
Serotonin 7 (5-HT7) receptor |  | Inhibitor | [1] |
Serotonin transporter |  | Inhibitor | [1] |
Ref 1 | Bioorg Med Chem Lett. 2010 Jan 15;20(2):628-31. Epub 2009 Nov 20.Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. To Reference |